Reaction

Oedema Mouth reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,259 reports · 43 co-occurring drugs

As of the last recalculation, Oedema Mouth appears in 3,259 FAERS reports alongside 43 co-occurring drug terms. The strongest observed disproportionality signal is NICOTINE POLACRILEX (PRR 12.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Nicotine Polacrilex	73	12.4	12.5
Nicotine Polacrilex Mini	20	8.6	8.6
Nicotine Polarilex	20	8.6	8.6
Felodipine Extended-Release Tablets	14	7.9	7.9
Felodipine	14	7.9	7.9
Alendronate Sodium	117	7.6	7.7
Enalapril Maleate	27	7.0	7.0
Glycerin, Lidocaine	15	6.9	6.9
Asenapine Maleate	9	6.6	6.7
Losartan Potassium And Hydrochlorothiazide	12	6.6	6.6
Miconazole Nitrate	9	6.6	6.6
Docosanol	15	6.6	6.6
Varenicline Tartrate	69	5.6	5.6
Heparin Sodium	12	5.6	5.6
Theophylline	10	5.6	5.6
Alteplase	13	5.5	5.6
Theophylline Anhydrous	10	5.2	5.2
Drs. Clotrimazole	9	5.0	5.0
Family Wellness Clotrimazole	9	5.0	5.0
Clotrimazole Topical	9	5.0	5.0
Raloxifene Hydrochloride	11	4.8	4.8
Fesoterodine Fumarate	8	4.7	4.7
Valsartan And Hydrochlorothiazide	10	4.7	4.7
Nicotine	29	4.6	4.6
Ziprasidone Mesylate	10	4.5	4.5
Zoledronic Acid	28	4.5	4.5
Clarithromycin	23	4.3	4.3
Granisetron Hydrochloride	7	4.3	4.3
Lisinopril And Hydrochlorothiazide Tablets	5	4.1	4.1
Iohexol	5	3.9	3.9
Bicalutamide	9	3.8	3.8
Granisetron	6	3.7	3.7
Ziprasidone	10	3.6	3.6
Metformin Hcl	30	3.5	3.5
Buprenorphine Hydrochloride, Naloxone Hydrochloride	12	3.2	3.2
Deferasirox	12	2.9	2.9
Naproxen Sodium Tablet	23	2.8	2.8
Imatinib Mesylate	12	2.8	2.8
Conjugated Estrogens And Medroxyprogesterone Acetate	9	2.4	2.4
Peginterferon Alfa-2A	19	2.3	2.3
Ribavirin	21	2.1	2.1
Lapatinib	5	2.1	2.1
Vigabatrin	4	1.8	1.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.